Video 6
Disclaimer: Individual results vary. Local etanercept treatment for the indications below is off-label. Please see the Legal Disclaimer. Maintenance dosing, usually weekly, but sometimes as little as monthly, is necessary for optimal effect. The methods of local etanercept treatment utilized for these patients are patented inventions of the INR[1].
Son discussing his father's rapid and significant clinical improvement (2005)* video length 3:49

This video is an interview with a son discussing his father's clinical response to initiation of local etanercept at the INR. For the published results please see TNF-alpha Modulation for Treatment of Alzheimer's Disease: A 6-Month Pilot Study. Tobinick E, Gross H, Weinberger A, Cohen H. MedGenMed 2006; 8(2) :25.
INR 100 UCLA Medical Plaza, Suites 205-210 Los Angeles (310) 824-6199 Orange County: 361 Hospital Road, Suite 428 Newport Beach

Copyright ©2010, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. [1]U.S. patents 6,537,549; 6,982,089; 7,214,658; 7,629,311; Australian patent 758,523; and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Please see the medical and legal disclaimer.
<Map and Directions><Appointments><Physician Training Program><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Videos>